CCL2 and metabolic dysfunction-associated steatotic liver disease: Analyzing non-autoimmune inflammatory liver diseases, and referring to the reports of obese patients with NAFLD showed that elevated serum levels of MCP-1 were also found in patients diagnosed with NAFLD [44].